Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
Johnson & Johnson is facing an Invokana lawsuit from a Louisiana man who alleges he developed serious injuries after taking the popular type-2 diabetes medication.
According to his Invokana lawsuit, plaintiff David L. used the medication from June 2015 to July 2015 to help control his diabetes.
However, soon after beginning to take his medication as prescribed, David reportedly began suffering serious Invokana side effects, including diabetic ketoacidosis.
Diabetic ketoacidosis is a condition in which the body produces high levels of blood acids called ketones. Patients often develop this condition when the body cannot produce enough insulin, which prevents the body from converting fat into energy, and results in acids building up in the bloodstream.
Insulin, the primary source of energy for cells, is produced by the pancreas and is responsible for converting food into energy. Type-2 diabetes patients cannot adequately produce insulin, which can cause the patients to experience diabetic shock and other serious symptoms.
Invokana (canagliflozin) was approved by the FDA in March 2013 as a type-2 diabetes medication.
The medication is part of the sodium glucose costransporter 2 (SGLT2) inhibitor family of drugs, and is manufactured by Johnson & Johnson subsidiary Janssen Pharmaceuticals.
Invokana works by preventing the kidneys from reabsorbing glucose, or sugar. Rather than filtering the glucose from blood into the urine, then reabsorbing the glucose into the body as happens in non-diabetic patients, Invokana causes patients to excrete the excess glucose through the urine.
Invokana Lawsuit
David’s Invokana lawsuit alleges that although the manufacturer has advertised Invokana as an effective diabetes treatment, a number of patients have reportedly developed diabetic ketoacidosis as a result of taking the medication.
David himself had to contend with hospitalization and recovery, says his lawsuit.
David states that there were no warnings or indications on the drug’s label regarding the risk of ketoacidosis, nor did the pharmaceutical company notify his physician.
The Invokana Lawsuit is Case 2:16-cv-02329, in the U.S. District Court for the Eastern District of Louisiana.
In general, Invokana lawsuits are filed individually by each plaintiff and are not class actions.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or class action lawsuit is best for you. Hurry — statutes of limitations may apply.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2024 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
Get Help – It’s Free
Join a Free Invokana Class Action Lawsuit Investigation
If you or a loved one suffered ketoacidosis or kidney failure after taking Invokana, you may have a legal claim. See if you qualify to pursue compensation and join a free diabetes medication class action lawsuit investigation by submitting your information for a free case evaluation.
An attorney will contact you if you qualify to discuss the details of your potential case.
Please Note: If you want to participate in this investigation, it is imperative that you reply to the law firm if they call or email you. Failing to do so may result in you not getting signed up as a client, if you qualify, or getting you dropped as a client.
Oops! We could not locate your form.
